scorecardresearch
Add as a preferred source on Google
Wednesday, January 14, 2026
TopicDiabetes

Topic: Diabetes

New subtype of diabetes found in India could change how rare forms of disease are treated

The landmark achievement in diabetes research in the country could potentially transform how certain rare forms of the disease are diagnosed & treated worldwide.

Silent threat of diabetic retinopathy: Eye doctors bat for advanced treatments to be part of AB-PMJAY

Diabetic retinopathy affects 30 lakh Indians and can lead to vision loss. Advanced therapies include costly injections currently not covered under Centre’s healthcare scheme.  

Fat-busting drug Mounjaro launched in India. Here’s how much it will cost

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, it has since become a global blockbuster.

Swapping ghar ka khaana with ready-to-eat foods? 66% beverages have high sugar, 97% snacks high fat

Govt-funded study analysed front and back of labels of 432 popular packaged food products including breakfast cereals, idli mixes, porridges, soup mixes, beverages and extruded snacks.

Cipla set to bring Afrezza, 1st inhalable insulin since Exubera, to Indian markets by 2025

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.

India had highest number of diabetics in the world in 2022, 62% were not on medication—Lancet report

Study conducted by NCD Risk Factor Collaboration (NCD-RisC) and WHO. Findings part of first global analysis of trends in both diabetes rates and treatment across countries.

Danish scientists create ‘smart’ insulin with ‘on-off’ switch to target blood sugar highs & lows

Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other sugars like fructose, to aid treatment of all types of diabetes.

Fried, baked, ultra-processed foods fuel India’s diabetes epidemic—1st-of-its-kind study by ICMR & MDRF

Study published in International Journal of Food Sciences and Nutrition says having foods low in advanced glycation end products can mitigate burden of obesity-linked type 2 diabetes.

How semaglutide is emerging as A-Z drug, helping with diabetes, alcohol cravings & more

Health experts are now looking at whether semaglutide can also curb alcohol cravings among addicts. A look at how this GLP-1 category drug functions in humans.

Chinese scientists see sweet success, reverse type-1 diabetes in woman using her own stem cells

Study in journal Cell says fat cells were extracted from the patient & altered to develop into any type of cell in the body. She has been insulin-independent for a yr, the 1st such case.

On Camera

India has 7.4% growth, but faltering tax revenue could have implications in coming fiscal year

In the first eight months of the current fiscal year, New Delhi’s net tax intake didn’t even hit the halfway mark of what it expects to collect by March 31.

Grounded no more: Andhra govt revives no-frills Dagadarthi airport near Nellore to boost south coast link

As Visakhapatnam readies a mega airport, the Andhra Pradesh government has revived its shelved Dagadarthi project, aiming to boost cargo and connectivity on the south coast.

Army chief lambasts Chinese infra push in Shaksgam Valley. ‘We consider it illegal action’

Speaking at annual press conference, Army chief reiterated that India does not recognise 1963 Sino-Pakistan border pact under which Pakistan illegally ceded Shaksgam Valley to China.

Thank you Donald Trump, again. India now has reason to shed fear of trade deals and risky reform

UK, EFTA already in the bag and EU on the way, many members of RCEP except China signed up, and even restrictions on China being lifted, India has changed its mind on trade.